Evidence map›Paper›PMID 38049320›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2023

[Humanized anti-CD25 monoclonal antibody as a salvage therapy for steroid-refractory acute graft-versus-host disease after hematopoietic stem cell transplantation].

Y X Wu, D P Wu, X Ma, S S Jiang, M J Hou, Y T Jing, B Liu, Q Li, X Wang, Y B Wu and 1 more

Open access · greenAbstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Y X WuSoochow Hopes Hematology Hospital, Suzhou 215006, China.
D P WuJiangsu Institute of Hematology, National Clinical Research Center for Hematology Disease, NHC Key Laboratory of Thrombosis and Hemostasis, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
X MaJiangsu Institute of Hematology, National Clinical Research Center for Hematology Disease, NHC Key Laboratory of Thrombosis and Hemostasis, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
S S JiangSoochow Hopes Hematology Hospital, Suzhou 215006, China.
M J HouSoochow Hopes Hematology Hospital, Suzhou 215006, China.
Y T JingSoochow Hopes Hematology Hospital, Suzhou 215006, China.
B LiuSoochow Hopes Hematology Hospital, Suzhou 215006, China.
Q LiSoochow Hopes Hematology Hospital, Suzhou 215006, China.
X WangSoochow Hopes Hematology Hospital, Suzhou 215006, China.
Y B WuSoochow Hopes Hematology Hospital, Suzhou 215006, China.
X H HuJiangsu Institute of Hematology, National Clinical Research Center for Hematology Disease, NHC Key Laboratory of Thrombosis and Hemostasis, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Soochow University · CN

Funding

Innovative and Applied Scientific Research Project of Professional Ability of Clinical Specialists RCLX2315016Su Zhou Industrial Park He He Yuan Da Blood Innovation Research Institute H221084Translational Research Grant of NCRCH 2020WSC06
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antibodies, MonoclonalGraft vs Host DiseaseHematopoietic Stem Cell TransplantationAcute DiseaseAdolescentAdultFemaleHumansMaleMiddle AgedRetrospective StudiesSalvage TherapySteroidsYoung AdultAntibodies, MonoclonalSteroidsAcute graft-versus-host diseaseHematopoietic stem cell transplantationHumanized anti-CD 25 monoclonal antibody

Identifiers

PMID38049320
PMCPMC10630582
OpenAlexW4389346185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.